journal article·2015-05

Extracellular matrix components of adipose derived stromal cells promote alignment, organization, and maturation of cardiomyocytes in vitro

Ewa Przybyt, Marja J. A. van Luyn, Martin C. Harmsen

Publisher page

Abstract

Abstract Adipose derived stromal cells (ADSC) are relevant therapeutic agents to treat myocardial infarction (MI) in clinical trials. Soluble factors secreted by ADSC, such as growth factors and cytokines, suppress inflammation and apoptosis while promoting angiogenesis and the proliferation of cardiomyocytes (CM). Moreover, ADSC synthesize extracellular matrix (ECM) components into the intercellular space which might contribute to their therapeutic capacity. Thus, ADSC might directly modulate the post‐MI microenvironment through a combination of paracrine and juxtacrine signaling. In this study, the juxtacrine role of ADSC and ADSC‐derived ECM on the organization and maturation of CM was investiagated. Human ADSC synthesized and deposited a heterogenous and complex mixture of ECM components such as collagen I, III, IV, fibronectin, elastin as well as the matricellular protein periostin. Cocultures of rodent CM with human ADSC or with human ADSC‐derived ECM components enhanced the cardiomyocyte alignment, their intercellular connections and the maturation of their sarcomeres, while the proliferation rate of the CM was increased and their level of hypertrophy reduced. The use of human ADSC‐derived ECM could serve both to augment in vitro tissue‐engineered myocardial constructs and to improve myocardial remodeling after infarction. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 1840–1848, 2015.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Congenital heart defects research · Cardiac Fibrosis and Remodeling

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

University of Groningen University Medical Centre Groningen Department of Pathology and Medical Biology Cardiovascular Regenerative Medicine Research Group (CAVAREM) 9713 GZ Groningen The Netherlands

Funding

Translational Excellence in Regenerative Medicine · Groningen University Institute Drug Exploration (GUIDE) of the University of Groningen and the University Medical Center Groningen · J.K. de Cock Foundation and the Netherlands Organisation for Scientific Research · Netherlands Organisation for Health Research and Development [ZonMW grant; microscopical imaging was performed at the UMCG Imaging Center (UMIC)]

References (29)

Show source-provided references
1. 10.1016/j.yjmcc.2005.05.01210.1016/j.yjmcc.2005.05.012 ↗
2. 10.1016/j.carpath.2005.10.00610.1016/j.carpath.2005.10.006 ↗
3. 10.1016/j.cardiores.2006.11.03010.1016/j.cardiores.2006.11.030 ↗
4. 10.1016/j.actbio.2012.09.02810.1016/j.actbio.2012.09.028 ↗
5. 10.2174/1574888X1130804000210.2174/1574888X11308040002 ↗
6. 10.1186/1479-5876-11-3910.1186/1479-5876-11-39 ↗
7. Adipose stromal cells—Plastic type of cells with high therapeutic potential
8. 10.1161/CIRCRESAHA.112.30073010.1161/CIRCRESAHA.112.300730 ↗
9. 10.3727/096368912X63884710.3727/096368912X638847 ↗
10. 10.1016/j.jacc.2011.09.06510.1016/j.jacc.2011.09.065 ↗
11. 10.1098/rsif.2011.030110.1098/rsif.2011.0301 ↗
12. 10.1532/hsf.91710.1532/hsf.917 ↗
13. 10.1016/j.biomaterials.2012.07.01010.1016/j.biomaterials.2012.07.010 ↗
14. 10.1016/j.yjmcc.2009.07.01510.1016/j.yjmcc.2009.07.015 ↗
15. 10.1002/jcp.2232210.1002/jcp.22322 ↗
16. 10.1073/pnas.95.6.297910.1073/pnas.95.6.2979 ↗
17. 10.1152/ajpheart.00986.200310.1152/ajpheart.00986.2003 ↗
18. 10.1161/CIRCULATIONAHA.112.11838010.1161/CIRCULATIONAHA.112.118380 ↗
19. 10.1126/science.116468010.1126/science.1164680 ↗
20. 10.1016/j.yjmcc.2009.08.00310.1016/j.yjmcc.2009.08.003 ↗
21. 10.1152/physrev.00008.201110.1152/physrev.00008.2011 ↗
22. 10.6061/clinics/2013(10)0910.6061/clinics/2013(10)09 ↗
23. 10.1002/path.228110.1002/path.2281 ↗
24. 10.1111/j.1524-475X.2010.00636.x10.1111/j.1524-475X.2010.00636.x ↗
25. 10.1111/j.1524-4725.2012.02495.x10.1111/j.1524-4725.2012.02495.x ↗
26. 10.1186/1479-5876-10-17210.1186/1479-5876-10-172 ↗
27. 10.1002/jcp.2106810.1002/jcp.21068 ↗
28. 10.1089/ten.tea.2009.063510.1089/ten.tea.2009.0635 ↗
29. 10.1016/j.biomaterials.2013.09.08310.1016/j.biomaterials.2013.09.083 ↗